Ireland
--:--IST
Recruiting Not applicable

Isokinetic Strength Training in Hemiparetic Patient With Knee Extension Thrust

NCT05887440 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2023-08-21
Last updated
2023-09-05

Condition(s) studied

Hemiparesis/Hemiplegia (One Sided Weakness/Paralysis)Gait Disorder

Investigational drug(s) / intervention(s)

isokinetic strength training of knee extensor and flexor muscles

isokinetic strength training of knee extensor and flexor muscles: Patients underwent an isokinetic strength training program with 3 sessions per week during five weeks. Program consists of excentric contraction of knee flexor and extensor muscles (4 x 7 Contractions at 30°/s) and concentric contractions at maximal speed where patients can perform 40% of his maximal isometric torque for knee flexor and extensor muscles (2x10 for knee flexors and 2x10 for knee extensors)

Study summary

The purpose of this study is to assess the impact of an isokinetic strength training of knee flexor and extensor muscles on walking performance in hemiparetic patients with knee extension thrust.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Hemiparetic patient (hemorragic or ischemic stroke) * Subacute stage (\< 6 Months) ou chronic stage of stroke (\> 6 months) (6 patients in each group) * Age between 18 and 75 years * Able to walk 10 meters independently without any assistive devices * Knee extension thrust during stance phase of gait cycle (rapid posterior movement of the knee toward extension) * Scheduled rehabilitation program with isokinetic strength training * affiliation to a social security * Patients who received and signed informed consent Exclusion Criteria: * Major comprehension deficit that not allow to give informed consent and participate to isokinetic strength training (assessed with comprehension subscore of Langague screening Test) * non stable (unstable cardiovascular condition) * musculoskeletal disorders with knee pain that not allowed isokinetic strength training * Botulinum toxin injection less than 3 months or repeated injection in lower limb, * Proprioception trouble assessed with proprioception section of the Fugl-Meyer Assessment \[FMA-P\] 0/2 * spasticity of triceps surae ≥2 (Modified Ashworth scale) * ankle dorsiflexion angle less than 90° * pregnant women or breastfeeding * persons with safety measure

Primary outcome measure(s)

  • spontaneous walking speed — 25 weeks
    Spontaneous walking speed of hemiparetic patients recorded with 3D gait analysis

Trial sites (1)

FacilityCityRegionStatus
CHU de Rennes Rennes France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05887440 on ClinicalTrials.gov ↗ ← All trials in France